BI
AGIO icon

BVF Inc’s Agios Pharmaceuticals AGIO Stock Holding History

BVF Inc’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,073,755
Closed -$35.3M – 52
2024
Q4 		$35.3M Sell
1,073,755
-116,352
-10% -$5.47M 1.2% 20
2024
Q3 		$52.9M Hold
1,190,107
– – 1.55% 20
2024
Q2 		$51.3M Buy
+1,190,107
New +$43M 1.44% 22
2014
Q1 		– Sell
-196,996
Closed -$47K – 29
2013
Q4 		$47K Hold
196,996
– – 0.01% 25
2013
Q3 		$5.51M Buy
+196,996
New +$5.44M 0.95% 20

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BVF Inc's AGIO Position: Q1 2025 in Review

BVF Inc sold out of Agios Pharmaceuticals (AGIO) in Q1 2025, closing a stake of 1,073,755 shares — an estimated $35.3M sold.

BVF Inc first reported a position in AGIO in Q3 2013 and held it in 5 quarters. The position peaked at $52.9M in Q3 2024. 221 funds tracked by Wall St. Rank hold AGIO as of Q1 2025.

  • BVF Inc reported no remaining Agios Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • BVF Inc sold 1,073,755 Agios Pharmaceuticals shares in Q1 2025, an estimated $35.3M.
  • BVF Inc first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • BVF Inc's Agios Pharmaceuticals position peaked at $52.9M in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2025.

Based on BVF Inc's 13F filing for Q1 2025, filed 15 May 2025.